vs
ALEXANDERS INC（ALX）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是ALEXANDERS INC的1.3倍（$69.8M vs $53.3M），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -4.7%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -6.9%）
亚历山大公司是一家房地产投资信托企业，在纽约大都会区持有七处物业，包括彭博有限合伙企业总部所在地列克星敦大道731号。该公司由乔治·法卡斯和路易斯·施瓦德伦于1928年创立，目前由沃那多房产信托控股。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
ALX vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.3倍
$53.3M
营收增速更快
RIGL
高出25.9%
-4.7%
两年增速更快
RIGL
近两年复合增速
-6.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $53.3M | $69.8M |
| 净利润 | — | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | — | 384.0% |
| 营收同比 | -4.7% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $0.75 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALXRIGL
| Q4 25 | $53.3M | $69.8M | ||
| Q3 25 | $53.4M | $69.5M | ||
| Q2 25 | $51.6M | $101.7M | ||
| Q1 25 | $54.9M | $53.3M | ||
| Q4 24 | $55.9M | $57.6M | ||
| Q3 24 | $55.7M | $55.3M | ||
| Q2 24 | $53.4M | $36.8M | ||
| Q1 24 | $61.4M | $29.5M |
净利润ALXRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $6.0M | $27.9M | ||
| Q2 25 | $6.1M | $59.6M | ||
| Q1 25 | $12.3M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $6.7M | $12.4M | ||
| Q2 24 | $8.4M | $-1.0M | ||
| Q1 24 | $16.1M | $-8.2M |
毛利率ALXRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率ALXRIGL
| Q4 25 | — | 33.2% | ||
| Q3 25 | — | 40.9% | ||
| Q2 25 | — | 60.1% | ||
| Q1 25 | — | 23.9% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | — | 25.4% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | -23.6% |
净利率ALXRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | 11.2% | 40.2% | ||
| Q2 25 | 11.9% | 58.6% | ||
| Q1 25 | 22.4% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | 12.0% | 22.5% | ||
| Q2 24 | 15.7% | -2.8% | ||
| Q1 24 | 26.2% | -27.9% |
每股收益（稀释后）ALXRIGL
| Q4 25 | $0.75 | $14.11 | ||
| Q3 25 | $1.16 | $1.46 | ||
| Q2 25 | $1.19 | $3.28 | ||
| Q1 25 | $2.40 | $0.63 | ||
| Q4 24 | $2.39 | $0.82 | ||
| Q3 24 | $1.30 | $0.70 | ||
| Q2 24 | $1.63 | $-0.06 | ||
| Q1 24 | $3.14 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $128.2M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $109.2M | $391.5M |
| 总资产 | $1.1B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资ALXRIGL
| Q4 25 | $128.2M | $155.0M | ||
| Q3 25 | $286.1M | $137.1M | ||
| Q2 25 | $313.0M | $108.4M | ||
| Q1 25 | $319.9M | $77.1M | ||
| Q4 24 | $338.5M | $77.3M | ||
| Q3 24 | $354.8M | $61.1M | ||
| Q2 24 | $410.9M | $49.1M | ||
| Q1 24 | $526.3M | $49.5M |
总债务ALXRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益ALXRIGL
| Q4 25 | $109.2M | $391.5M | ||
| Q3 25 | $128.3M | $117.6M | ||
| Q2 25 | $145.4M | $81.9M | ||
| Q1 25 | $163.1M | $18.6M | ||
| Q4 24 | $176.9M | $3.3M | ||
| Q3 24 | $190.7M | $-14.6M | ||
| Q2 24 | $212.5M | $-29.9M | ||
| Q1 24 | $230.1M | $-31.7M |
总资产ALXRIGL
| Q4 25 | $1.1B | $513.6M | ||
| Q3 25 | $1.3B | $242.5M | ||
| Q2 25 | $1.3B | $206.7M | ||
| Q1 25 | $1.3B | $176.0M | ||
| Q4 24 | $1.3B | $164.0M | ||
| Q3 24 | $1.4B | $139.4M | ||
| Q2 24 | $1.5B | $128.4M | ||
| Q1 24 | $1.4B | $126.5M |
负债/权益比ALXRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $73.4M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ALXRIGL
| Q4 25 | $73.4M | $22.0M | ||
| Q3 25 | $-9.3M | $24.0M | ||
| Q2 25 | $43.6M | $30.5M | ||
| Q1 25 | $15.7M | $-893.0K | ||
| Q4 24 | $54.1M | $14.5M | ||
| Q3 24 | $-5.0M | $21.7M | ||
| Q2 24 | $11.5M | $302.0K | ||
| Q1 24 | $16.8M | $-5.0M |
现金转化率ALXRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | -1.55× | 0.86× | ||
| Q2 25 | 7.12× | 0.51× | ||
| Q1 25 | 1.28× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | -0.75× | 1.75× | ||
| Q2 24 | 1.37× | — | ||
| Q1 24 | 1.04× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
